From: In vivo generated autologous plasmin assisted vitrectomy in young patients
Age | Gender/eye | Diagnosis | Inj-Op ınterval (day) | Treatment | No of attempts for PVD | Preop VA LogMAR | Postop VA LogMAR | Final status | Follow-up time (month) | Complication |
---|---|---|---|---|---|---|---|---|---|---|
39 | M/L | Chronic RD | 3 | PPV, LE | 3 | 2.00 | 0.70 | Attached | 23 | None |
12 | F/L | Chronic RD | 3 | PPV | 2 | 2.40 | 0.70 | Attached | 18 | Re-RD |
31 | F/R | Chronic RD | 3 | PPV | 3 | 2.40 | 1.00 | Attached | 14 | ERM |
17 | M/R | Traumatic RD | 3 | PPV, LE | 1 | 1.00 | 0.70 | Attached | 14 | None |
13 | M/L | Traumatic RD | 3 | PPV, LE | 3 | 0.70 | 0.20 | Attached | 26 | None |
12 | F/L | OPM | 3 | PPV | 4 | 1.30 | 0.30 | Attached | 14 | None |
39 | M/R | Traumatic RD | 3 | PPV | 1 | 1.80 | 0.70 | Attached | 15 | None |
39 | F/L | VPT | 3 | PPV | 2 | 1.30 | 0.10 | Attached | 26 | None |
10 | M/R | MH | 3 | PPV | 2 | 1.00 | 0.70 | Attached | 25 | None |
19 | M/R | VPT | 3 | PPV, LE | 2 | 2.00 | 0.40 | Attached | 23 | None |
29 | F/L | Chronic RD | 3 | PPV | 1 | 1.30 | 0.10 | Attached | 12 | None |
23 | F/R | Chronic RD | 3 | PPV, LE | 2 | 1.80 | 0.50 | Attached | 18 | None |
21 | M/L | VPT | 3 | PPV, LE | 2 | 1.00 | 1.00 | Attached | 25 | Re-RD |
21 | F/L | OPM | 3 | PPV | 2 | 1.30 | 0.70 | Attached | 14 | None |
19 | M/L | VPT | 3 | PPV, LE | 2 | 0.50 | 0.50 | Attached | 23 | ERM, Re-RD |
24 | F/L | Chronic RD | 3 | PPV, LE | 1 | 1.30 | 0.40 | Attached | 23 | None |
33 | M/R | Chronic RD | 3 | PPV, LE | 1 | 0.50 | 0.10 | Attached | 16 | None |